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Herpes simplex virus type 1 (HSV-1) contains three DNA replication origins (ori) of two types. The oriL is located in the center of the unique
long sequences, whereas two copies of oriS, which are structurally different from oriL, are within the reiterated sequences flanking the unique short
sequences. Recombinant viruses were constructed from ts+7, which contains a deletion of oriL sequences, to have either the β-galactosidase gene
or the supF amplicon integrated into the thymidine kinase locus. Rescue recombinants also were constructed from the supF-containing
recombinant to restore the deleted oriL to the wild type sequences. These recombinants were subjected to mutagenesis assays. Results
demonstrated that ts+7 viruses with the deletion in oriL sequences replicated both target genes with higher fidelity compared to those derived from
the parental strain KOS. Possible mechanisms leading to the high fidelity of DNA replication mediated by viruses without intact oriL sequences
are discussed.
© 2005 Elsevier Inc. All rights reserved.Keywords: Herpes simple virus; DNA polymerase; Replication fidelity; Origin of DNA replication; SupF mutagenesisIntroduction
Herpes simplex virus (HSV) contains three copies of the
DNA replication origin (ori) of two types. One origin is located
in the center of the unique long sequences (oriL), whereas the
other two copies, which are structurally different from oriL, are
located within the repeated sequences flanking the unique short
sequences (oriS) (Quinn and McGeoch, 1985; Stow, 1982; Stow
and McMonagle, 1983). Although it is not known why HSV
maintains three copies of the origin sequences, it has been
demonstrated that recombinants lacking either oriL or both
copies of oriS are able to replicate efficiently in infected cells
(Igarashi et al., 1993; Polvino-Bodnar et al., 1987). However, it
is unlikely that these sequences are functionally redundant.
These two types of origin may have different roles in the viral
life cycle, in addition to their roles in the initiation of DNA
replication. They are structurally different, despite the extensive
sequence similarity. In particular, oriS comprises an imperfect⁎ Corresponding author. Fax: +1 315 464 7674.
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doi:10.1016/j.virol.2005.12.01145-bp palindrome (Stow and McMonagle, 1983), whereas oriL
is a perfect 144-bp palindrome (Gray and Kaerner, 1984; Quinn
and McGeoch, 1985; Weller et al., 1985). Study from
Hardwicke and Schaffer (1997) also demonstrates that, in
both undifferentiated and nerve growth factor (NGF)-induced
differentiated PC12 cells, oriL-dependent DNA replication is
enhanced by dexamethasone (DEX), whereas oriS function, but
not oriL, is repressed by NGF. These findings suggest the
possibility of different roles for oriL and oriS in the HSV life
cycle, including activities involved in both latent and lytic
infections (Hardwicke and Schaffer, 1997). It is also suggested
that these sequences may be involved in the temporal regulation
of gene expression (Hardwicke and Schaffer, 1997) as oriL is
located upstream of two divergently transcribed early genes,
UL29 and UL30, which encodes the major single-stranded
DNA binding protein, ICP-8, and the DNA polymerase (Pol),
respectively, and oriS is flanked by immediate-early genes of
ICP4 and either ICP22 or ICP47. The presence of two copies of
oriS within the repeat sequences is suggested to be a result of
sequence conversion of the repeat sequences (Igarashi et al.,
1993).
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interest in term of its possible effect on viral DNA replication,
since both Pol and ICP-8 play critical roles in viral DNA
replication. Mutations within the Pol can affect the fidelity of
DNA replication (Hwang and Hwang, 2003; Hwang et al.,
1997, 1999, 2002, 2004). ICP8 proteins are found to be
associated with DNA repair and recombination proteins in
infected cells (Taylor and Knipe, 2004). In this study, we
examined whether the absence of oriL sequences in the HSV-1
virus affected the fidelity of viral DNA replication.
Results and discussions
Construction of Lac Z recombinants
We previously applied the β-galactosidase (Lac Z) muta-
genesis assay to examine the Lac Z mutation frequency
replicated in a recombinant tkLTRZ1 (Davar et al., 1994),
which has Lac Z gene inserted in the thymidine kinase (tk)
locus, derived from the HSV-1 strain KOS. In order to examine
the effect of lacking the oriL on DNA replication fidelity, the
ts+7 mutant virus (Polvino-Bodnar et al., 1987), which contains
a deletion of 148-bp within the oriL sequences, was modified to
contain the Lac Z gene in its tk locus. Such a deletion loses the
perfect palindromic structure of the oriL and results in the failure
of initiating the origin-dependent DNA replication in the
transient DNA replication assay (Polvino-Bodnar et al.,
1987). Two independent recombinants, ts+7/Lac Z-A and -B
(Fig. 1A), were isolated from independent transfection experi-
ments and twice plaque-purified to homogeneity. Southern
analysis confirmed that both ts+7/Lac Z recombinants
contained the Lac Z gene inserted into the tk locus (Fig. 1B).
A probe, consisting of the PstI 840-bp fragment of the tk gene
(Fig. 1A), hybridized to an 840-bp band, corresponding to the
PstI-digested, of wild type KOS DNA (Fig. 1B, left panel, lane
2). A shift from the 840-bp band to a 6.4-kb band was detected
in PstI-digested DNA isolated from tkLTRZ1, ts+7/Lac Z-A,
and -B DNA (Fig. 1B, left panel, lanes 1, 3, and 4, respectively).
The MluI 780-bp probe, prepared from the Lac Z gene (Fig.
1A), failed to detect a hybridization signal from PstI-digested
KOS DNA (Fig. 1B, right panel, lane 2), while a 6.4-kb band
was detected in PstI-digested DNA from tkLTRZ1, ts+7/Lac Z-
A, and -B (Fig. 1B, right panel, lanes 1, 3, and 4, respectively).
Both probes hybridized to plasmid DNA at the correct sizes
(Fig. 1B, right panel, lane 5 and Fig. 1B, right panel, lane 5).
Therefore, both ts+7/Lac Z-A and -B recombinants contained
the Lac Z gene and were homogeneous.
Lac Z mutagenesis assay
Single plaques were isolated from ts+7/Lac Z-A and -B,
amplified in Vero cells, and designated as viral stocks. Lac Z
mutagenesis was performed to examine the mutation frequency
of the Lac Z gene as described in Materials and methods.
Recombinant stocks of ts+7/Lac Z-A and -B exhibited mutation
frequencies of 0.01% and 0.008%, respectively (Table 1), which
were lower than the frequencies observed for tkLTRZ1 ininfected cells (0.015%) (Hwang et al., 2003). The low Lac Z
mutation frequency replicated by ts+7 recombinants is surpris-
ing. Because of the low mutation frequency, it is necessary to
examine a larger number of progeny viruses in order to reveal a
more accurate frequency. However, a bias may be resulted from
the isolation of sister mutants derived from the same mutants.
Therefore, a different approach was used. Three plaques were
isolated from each ts+7/Lac Z recombinant virus, amplified, and
subjected to mutagenesis assay. It is noted that a viral inoculation
with 100–200 pfu should not give rise to inoculation with a pre-
existing mutant. Progeny viruses were harvested at 72 h post-
infection and their titers were determined. Results demonstrated
that ts+7/Lac Z recombinants replicated the Lac Z gene with a
significantly higher fidelity (P b 0.05 and P b 0.001 for ts+7/Lac
Z-A and -B, respecitively) than tkLTRZ1, with mutation
frequencies ranging from 2- to 10-fold less (Table 1). Although
ts+7/Lac Z-B recombinant replicated with a lower mutation
frequency relative to that of ts+7/Lac Z-Avirus, the difference is
not statistically significant (P = 0.1846).
Analyses of UL29 and UL30 genes
Both viral DNA polymerase (UL30) and ICP-8 proteins
(UL29) are essential for viral DNA replication and located
divergently to the oriL. Additionally, experimental data have
demonstrated that mutations in the catalytic subunit of HSV-1
DNA polymerase, either in the polymerase or exonuclease
domains, have been shown to have a direct effect on replication
fidelity (Hwang and Hwang, 2003; Hwang et al., 1997, 1999,
2002, 2004). It is possible that ts+7-derived recombinants may
acquire mutations in both genes, resulting in higher fidelity. To
rule out this possibility, we sequenced both the UL29 and UL30
genes using either the cloned DNA fragments (the UL29 gene)
or the PCR-amplified products (the UL30 gene). The plasmids
pGEM-ts+7/Lac Z-UL29-A and -B, which contain the entire
UL29 open reading frame, oriL, and the 5′ portion of UL30,
were constructed from ts+7/Lac Z-A and -B, respectively, and
sequenced as described in Materials and methods. PCR-
amplified UL30 sequences also were sequenced as previously
described (Hwang et al., 2002, 2004). Sequencing results did
not discover any changes in the coding sequences of both genes,
compared to those of KOS (Gao et al., 1988; Gibbs et al., 1985).
However, an insertion of 2 Cs in the polynucleotide runs of 11
Cs, resulting in 13 Cs, located upstream of the UL29 coding
sequence was found (data not shown). It also is noted that strain
17 contains the runs of only 9 Cs at this region (McGeoch et al.,
1988), suggesting that the difference may be a polymorphism.
Sequencing of both UL29 and UL30 genes also demonstrated
that the ts+7 mutants and the derivatives are derived from the
strain KOS. Therefore, the altered mutation frequency observed
in ts+7 recombinants does not appear to be the result of the
mutation ofUL29 andUL30 genes. However, we do not rule out
the possibility that these recombinants may acquire mutation in
other genes, which are essential for viral DNA replication and
may play a role affecting the replication fidelity (see below).
Therefore, experiments with another reporter were carried out to
further test replication fidelity.
Fig. 1. Maps and Southern blot analysis of ts+7/Lac Z recombinant. (A) Map of ts+7 and ts+7/Lac Z recombinants. The top line denotes the genome of HSV-1 with the
relative locations of three origins of DNA replication (oriL and oriS). Line 1, designated as ts+7, shows an enlarged region flanking the HSV-1 tk locus with the relative
PstI restriction sites. The relative position of the tk probe used for Southern analysis is also shown. Line 2, designated as ts+7/Lac Z, shows the relative position of the
inserted Lac Z gene, which is under the control of the MoMLV LTR promoter. The relative BamHI restriction sites of the Lac Z DNA are also shown. The insertion of
the Lac Z construct that results in the destruction of the PstI site in the tk locus is indicated by parentheses. The relative locations of the tk and Lac Z probes are shown.
The corresponding size of the BamHI and PstI fragments, present in ts+7/lac Z recombinants, are shown on the bottom lines. (B) Southern blot analyses. Southern blot
analysis using the tk PstI 849-bp probe is shown on the left panel. Lanes 1 to 4 depicts PstI-digested genomic DNA isolated from Vero cells infected with tkLTRZ1,
KOS, ts+7/Lac Z-A, and -B, respectively. Lane 5: BamHI-digested ptkLTRZ1 plasmid DNA (control). The sizes of the molecular weight markers are shown on the left.
Southern analysis using the Lac Z 780-bp MluI probe is shown in the right panel. Lanes 1 to 4 depict PstI-digested DNA isolated from Vero cells infected with
tkLTRZ1, KOS, ts+7/Lac Z-A, and -B, respectively. Lane 5: BamHI-digested ptkLTRZ1 plasmids DNA (control). The sizes of the molecular markers are shown on the
left.
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The SupF reporter gene, which had been applied for the
studies of the effects of pol mutations in the replication fidelity,
was chosen for the next sets of experiments. Two independent
SupF-containing recombinants, ts+7/F-A and -C, were con-
structed, isolated, and purified under 10 μM gancyclovir
(GCV) selection as described previously (Hwang and Hwang,
2003). Southern blot analysis confirmed the insertion of the
SupF amplicon in the tk locus and demonstrated the
homogeneity of these recombinants (data not shown). Single
plaques of each recombinant virus were isolated by plaque
assay, amplified in Vero cells, and designated as viral stocks.To determine the SupF mutants present in these viral stocks,
SupF mutagenesis assay was performed and the relative
mutation frequency was determined. The mutation frequencies
were determined to be less than 0.001% and 0.0012% for the
stock of ts+7/F-A and -C recombinants, respectively (Table 2).
Approximately 100–200 pfu of each virus were inoculated into
1 × 105 Vero cells, incubated for 72 h, and the mutation
frequencies were determined. Experiment 1, shown in Table 2,
illustrates that both ts+7/F recombinants replicated with an
approximate 5-fold lower mutation frequency compared to
KOS/F-B virus (P b 0.001), which is derived from strain KOS
and contains an identical SupF amplicon in the tk locus
(Hwang et al., 2002).
Table 2
SupF mutation frequencies replicated by ts+7/F recombinants
Virus White colonies/Total colonies
(mutation frequency, %)
(P value a)
Stock
KOS/F-Bb 89/348,610 (0.026)
ts+7/F-A 0/78,855 (b0.001)
ts+7/F-C 1/82,539 (0.0012)
Rescue-A 3/13,791 (0.021)
Rescue-B 3/62,374 (0.0048)
Exp. 1
KOS/F-B 11/87,548 (0.013)
ts+7/F-A 6/282,083 (0.0021) (b0.001)
ts+7/F-C 6/235,947 (0.0025) (b0.001)
Exp. 2
KOS/F-B 8/82,774 (0.0097)
ts+7/F-A 8/303,180 (0.0026) (b0.01)
ts+7/F-C 2/99,533 (0.0020) (b0.05)
Rescue-A 34/277,005 (0.0123) (b0.05) c
Rescue-B 11/106,091 (0.0104) (b0.01) c
Exp. 3
KOS/F-B 5/39,018 (0.013)
ts+7/F-A 4/144,107 (0.0028) (b0.05) d
ts+7/F-11C 2/70,061 (0.0029) (b0.05) d
a Chi-square test was used to determine the P values for mutation frequency,
compared to that of KOS/F.
b Data from reference Hwang et al. (2002).
c The P value for mutation frequency was compared to that of ts+7/F-C.
d The P value for mutation frequency was compared to that of KOS/F-B.
Table 1
Lac Z mutation frequency of ts+7/Lac Z recombinants
Virus Clear plaques/
Total plaques
Mutation frequency,
% (P value) a
Stock
tkLTRZ1b 0/2142 b0.047
ts+7/Lac Z-A 1/9509 0.010
ts+7/Lac Z-B 1/11,985 0.0083
Experiment
tkLTRZ1 5/27,180 0.018
ts+7/Lac Z-A1 c 2/25,876 0.0077
ts+7/Lac Z-A2 2/50,607 0.0040
ts+7/Lac Z-A3 1/19,850 0.0050
Sum 5/96,333 0.0052 (b0.05)
ts+7/Lac Z-B1 1/35,950 0.0028
ts+7/Lac Z-B2 1/53,994 0.0019
ts+7/Lac Z-B3 1/57,210 0.0017
Sum 3/147,154 0.0020 (b0.001)
a Chi-square test was used to determine the statistical significance.
b Data from reference Hwang et al. (2003) and assayed on Vero cells.
c Three different plaques were isolated, amplified on Vero cells, and subjected
to mutagenesis study.
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could contribute to the altered replication fidelity, both UL29
and UL30 genes were cloned and PCR-amplified, respectively,
and sequenced as described above. Results did not reveal any
changes in the coding sequences of both genes (data not shown)
with the exception of the inserted 2 Cs in the non-coding
sequences upstream of the UL29 open reading frame, identical
to that found in ts+7/Lac Z recombinants. It, however, remains a
possibility that these recombinants may acquire mutation in
other replicative proteins, which affect the replication fidelity.
For example, mutation in UL42, the processivity factor of the
catalytic subunit of Pol, could mediate an altered DNA
replication fidelity (Jiang and Hwang, unpublished data).
Studies from other system also demonstrate that mutations in
gene encoding proliferating cell nuclear antigen (PCNA), the
processivity factor of Pol δ, can induce an increase of mutation
frequency in vivo (Chen et al., 1999).
Construction of rescue recombinants
To rule out the possibility that the higher fidelity of DNA
replication mediated by ts+7 recombinants was due to a second
mutation in other genes of recombinants, experiments were
designed to rescue the partially deleted oriL sequences. Since
there is no direct approach to select and isolate rescue
recombinants, we took a two-step approach to revert the
partially deleted oriL to its wild type counterpart using two
newly constructed plasmids described below. This was done
first by the construction of a recombinant to contain the deletion
of oriL and partial pol sequences, and an insertion of DsRed2
gene expressing Red fluorescent protein. The altered sequences
allow a rapid screening of recombinants expressing Red
fluorescent marker, which can only propagate in a Pol cell
line because of the deletion in pol gene. The secondrecombinant will be rescued to contain the wild type sequences
of both oriL and pol sequences and can be isolated as that
lacking the expression of Red fluorescent marker and restoring
the ability to grow on Vero cells.
A recombinant, ts+7/F-Red2 (Fig. 2, line 4), with a deletion
of the N-terminal part of UL30 and an insertion of a fluorescent
DsRed2 marker, was constructed by transfection of pUL29/30-
Red2 into PolA5 cells, followed by superinfection with ts+7/F-
C recombinant virus. The resulting recombinant, ts+7/F-Red2,
which could only grow on PolA5 cells and express red
fluorescent protein, was isolated using fluorescent microscopy.
Recombinant ts+7/F-Red2 was purified to homogeneity. PCR
reaction using oligonucleotide primers ICP8-2 and Red-545
demonstrated that the DsRed2 gene was present in recombinant
ts+7/F-Red2 (Fig. 3B, lane 3), but not in wild type KOS/F-B or
ts+7/F-C (Fig. 3B, lanes 1 and 2, respectively). An internal
control, which amplified a 564-bp fragment of the UL42 gene,
was included in all reactions to rule out PCR failure in the
absence of a DsRed2 PCR product. Primers UL42-2 and UL42-
8 were used in this experiment. This PCR experiment also
demonstrated the homogeneity of rescue-A and -B recombi-
nants by the lack of DsRed2 PCR products (see below; Fig. 3B,
lanes 4 and 5).
Two independent rescue mutants, rescue-A and -B, were
then constructed by transfection of the plasmid pKS-UL29/
30 into PolA5 cells, followed by superinfection with ts+7/F-
Red2 recombinant virus. These constructs were identified by
the loss of DsRed2 expression and the ability to grow on
Fig. 2. Map of supF recombinants and plasmids. The top line denotes the genome of HSV-1 with the relative locations of the three origins of DNA replication (oriL
and oriS), UL29, and UL30 genes. Line 1 shows the relative restriction map spanning the UL29 gene, wild type oriL (closed box), the UL30 gene of KOS/F
recombinants. Line 2 shows the relative location of the deleted oriL (opened box) in ts+7/F recombinants. Line 3 shows the relative map of the plasmid pUL29/30-
Red2, which contains the N-terminal portion of UL29, partial oriL region, Pcmv-DsRed2, and the C-terminal portion of UL30. Line 4 shows the relative map of
recombinant virus ts+7/F-Red2, which contains the Pcmv-DsRed2 cassette inserted between UL29 and UL30. Line 5 shows the relative map of the plasmid pKS-
UL29/30, which contains the N-terminal portion of UL29, the entire oriL, and the N-terminal portion of UL30. Line 6 shows the relative map of rescue-A and -B
recombinants, which contains the rescued oriL sequence (closed box). Numbers depict the corresponding nucleotide positions in the HSV-1 genome, according to
McGeoch et al. (1988). The open reading frames of UL29, UL30, and DsRed2 are shown as arrows with solid lines. The relative locations of primers Red-545, ICP8-
2, and oriL-3′ are shown as arrows with dotted lines. The symbol of * depicted the relative location of the runs of Cs. Restriction enzymes depicted are: B, BamHI; Bs,
BsrGI; C, ClaI; E, EcoRI; N, NotI; P, PstI; S, SphI.
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wild type sequences of oriL and pol. As seen in Fig. 3B
(lanes 4 and 5), both rescue recombinants appeared to lose
the Pcmv-DsRed2 sequence as shown by a lack of Red2
amplification. To further confirm that these rescue recombi-
nants contain the intact oriL sequences, oligonucleotide
primers ICP8-2 and oriL-3′, corresponding to sequences
located upstream and downstream of the oriL sequence (Fig.
1B, line 6), were used to amplify the corresponding
sequences from DNA isolated from virus-infected cells. A
662-bp fragment was amplified from rescue-A and -B (Fig.
3C, lanes 4 and 5, respectively), consistent with the results
from KOS/F-B (Fig. 3C, lane 1). This result is in sharp
contrast to the 514-bp DNA fragment amplified from ts+7/F-
A and -C viral DNA (Fig. 3C, compare lanes 1, 4, and 5
with 2 and 3). Two PsiI restriction sites are shown to exist
in the 148-bp region that is the deleted component of the
palindromic sequence of oriL in the ts+7 genome (Fig. 3A).The presence of these restriction sites offers the advantage of
a quick diagnosis for the presence of oriL. The PCR-
amplified 662-bp fragment was digested with PsiI into three
fragments of 409, 157, and 96 bp (Fig. 3C, lanes 6, 9, 10),
suggesting the presence of full-length oriL, whereas the
products of ts+7/F recombinants were not cleaved by PsiI
(lanes 7 and 8). Furthermore, the multiple bands observed in
undigested DNA disappeared after PsiI digestion, suggesting
that these multiple bands are due to the secondary structures
formed by palindrome sequences. The presence of wild type
oriL sequences in rescue-A and -B recombinants was further
confirmed by direct sequencing of the PCR products that
were amplified from these viral DNAs (data not shown).
Both UL29 and UL30 genes were cloned and PCR-
amplified, respectively, and sequenced as described above.
Results did not reveal any changes in both genes, including
the runs of 11 Cs of the strain KOS sequence in the non-
coding sequences (data not shown).
Fig. 3. Analysis of rescued recombinants. (A) Map of sequences spanning the oriL region. The line, designated as KOS, shows the map of 662-bp DNA fragment
amplified from viral DNA containing the intact oriL sequence using primers ICP8-2 and OriL-3′. The line, designated as ts+7, shows the map of a 514-bp fragment
from ts+7 recombinants using the same primers. The relative size of the DNA fragment after PsiI digestion is shown. The closed box (in KOS) depicts the 148-bp
fragment within the oriL sequence, which is deleted in ts+7 (dashed box). Numbers provided refer to the nucleotide position within the HSV-1 genome. (B)
Homogeneity of recombinants with rescued oriL. PCR products were amplified using 2 primer pairs, ICP8-2 and Red-545 (see Fig. 2, line 3), and UL42-2 and UL42-
8 as described in the text. The corresponding PCR products are indicated on the right side. Lane 1, KOS/F-B; 2, ts+7/F-C; 3, ts+7/F-Red; 4, rescue-A; 6, rescue-B. The
DNAmarker is λ DNA digested with BstEII. (C) PCR products of the oriL-containing DNA fragment, amplified by PCR using primers ICP8-2 and oriL-3′. Lanes 1 to
5: PCR products; lanes 6 to 10: PCR products digested with PsiI. Lanes 1 and 6: KOS/F-B; 2 and 7: ts+7/F-A; 3 and 8: ts+7/F-C; 4 and 9: rescue-A; 5 and 10: rescue-B.
Lanes 2, 3, 7, and 8 are loaded with one-tenth volume (0.8 μl) of total PCR products relative to others (8 μl). The DNA marker (M) is a 50-bp DNA ladder (New
England Biolabs).
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mutation frequency
A second set of SupF mutagenesis experiments (Table 2,
Exp. 2) was then performed to measure the mutation
frequencies of the SupF gene by replicated various recombi-
nants, including the rescue recombinants. Results demonstrated
that rescue-A and -B recombinants replicated the SupF gene
with the frequencies of 0.0123% and 0.0104%, respectively,
comparable to KOS/F-B virus (0.0097%), while both ts+7/F-A
and -C recombinants exhibited approximately 5-fold lower
frequencies [0.0026% (P b 0.01) and 0.0020% (P b 0.05),
respectively] than KOS/F-B virus. Therefore, the increased
fidelity mediated by ts+7/F-A and -C recombinants is not due to
the effect of second site mutation in the viral genome; the
absence of oriL sequences in these recombinants plays the
critical role in replicating DNAwith high fidelity. However, it is
possible that the inserted 2 Cs upstream of the UL29 in ts+7
recombinants may contribute to the high fidelity of DNA
replication.Recombinant with the oriL deletion and 11 Cs replicates DNA
with a higher fidelity
To examine whether the 13 Cs present in ts+7/F recombi-
nants contribute to the increased DNA replication fidelity of the
SupF gene, a recombinant virus, ts+7/F-11C, was constructed to
contain only 11 Cs and a deletion of the 148-bp oriL core
sequences. Sequencing of the PCR products amplified from
virus-infected cell DNA confirmed the correct construct of the
recombinant virus. The SupF mutagenesis assay was performed
and results (Table 2, Exp. 3) demonstrated that the recombinant
ts+7/F-11C replicated the SupF gene with the mutation
frequency of 0.0029%, comparable to ts+7/F-A virus
(0.0028%), which contained the 13 Cs, while the KOS/F-B
recombinant replicated the SupF gene with a significant higher
mutation frequency [0.013% (P b 0.05)]. Therefore, the
insertion of 2 Cs within the run of 11 Cs does not contribute
to the observed higher fidelity of the SupF genes replicated by
the oriL deletion recombinants. The SupF mutagenesis studies
clearly demonstrate that recombinant with the intact oriL
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the oriL sequences and that the oriL sequences may have an
effect in maintaining a certain degree of infidelity during viral
DNA replication.
Implications
In this study, the effect of a deletion in the oriL sequence on
replication fidelity was examined. Results clearly demonstrated
that HSV-1 recombinants lacking an intact oriL sequence
replicated DNA with a higher fidelity compared to those with
the wild type oriL sequence. It is intriguing that HSV contains
three ori copies, yet recombinant viruses lacking either oriL or
the two copies of oriS can replicate efficiently in cultured cells
(Igarashi et al., 1993; Polvino-Bodnar et al., 1987). However,
mutants lacking both copies of oriS exhibit a slow accumulation
of viral DNA during the early stages of infection and a modest
reduction in progeny yields compared to those infected with
wild type virus, despite nearly equal amount of total viral DNA
synthesized in infected cells (Igarashi et al., 1993). These
differences in HSV phenotype require further detailed quanti-
tative investigations to examine the impact of the lack of both
copies of oriS in viral replication efficiency. Studies of ts+7 also
demonstrate that the oriL sequence is not required for virus
replication in vitro or in vivo, as this mutant can establish and
maintain latent infection, and reactivate from latency (Polvino-
Bodnar et al., 1987). However, ts+7 has a decreased burst size
relative to its KOS strain (96 vs.136) and forms slightly smaller
plaques than KOS virus (Polvino-Bodnar et al., 1987).
Although these differences may not be significant, it seems
that the presence of all three copies of origins is required for
efficient DNA replication. Therefore, careful examinations of
the replication efficiencies, such as amounts of DNA synthe-
sized and the growth curves, of ts+7 relative to its parental strain
KOS viruses are necessary. The information will be important to
imply whether the impact of the oriL deletion in viral replication
efficiency is co-related to the increased fidelity observed in this
study.
It has been shown that oriL and oriS respond differently to
nerve growth factor (NGF) and dexamethasone (DEX) in
differentiated or undifferentiated PC12 cells (Hardwicke and
Schaffer, 1997), suggesting the different roles for oriL and oriS
in the HSV life cycle. The results reported in this study also
suggest that maintaining oriL in the HSV genome may have an
important role in HSV biology, perhaps to maintain a certain
degree of infidelity during DNA replication and viral
propagation. It will be interesting to examine whether mutants
lacking both copies of oriS have an effect on DNA replication
fidelity.
Another important question is to determine the mechanism
responsible for the effect of oriL on replication fidelity. One
possible explanation is that the virus may use two mechan-
isms to synthesize a fixed amount of total DNA in infected
cells, which can be expressed as the amount of DNA derived
from the number of origin based initiation of DNA replication
times the number of unit length DNA (processive DNA
synthesis) from each initiation event. Recombinant viruslacking one origin will result in a decreased number of
independent initiation accompanied with an increased number
of processive synthesis. Therefore, there are fewer errors
resulted from the processive replication. This hypothesis can
be tested by measuring the amount of DNA synthesized in
infected cells, and by examining whether recombinant lacking
both copies of oriS also replicates DNA with a higher fidelity.
Another possibility is that oriL may affect promoters at long
distance, which may lead to altered expressions of other
replicative proteins and indirectly affect the replication
fidelity. Further studies, including the application of micro-
array experiments, may provide such information.
Materials and methods
Cells and viruses
Vero and PolA5 cells were grown and maintained as
described previously (Hwang et al., 1997). The characteristics
of recombinant viruses tkLTRZ1, which contains integrated Lac
Z gene under the control ofMoloneymurine leukemia virus LTR
promoter (LTR) in the tk locus (Davar et al., 1994) (kindly
provided by Dr. D.M. Coen), and KOS/F-B, which contains
integrated SupF amplicon in the tk locus (derived from the wild
type strain, KOS) (Hwang et al., 2002), have been previously
described. Recombinant viruses ts+7/Lac Z-A and -B were
constructed frommutant ts+7 (Polvino-Bodnar et al., 1987) with
the β-galactosidase (Lac Z) gene integrated in the thymidine
kinase (tk) locus. Recombinant viruses ts+7/F-A and -C were
constructed from mutant ts+7 with the SupF mutagenesis
cassette inserted into the tk locus. Recombinant virus ts+7/F-
Red2 was constructed from ts+7/F-C with the oriL and N-
terminal portion of the UL30 gene replaced with the Pcmv-Red2
sequence, which contains the DsRed2 gene (isolated from
pDsRed2; BD Biosciences) under the control of the CMV IE
promoter (Pcmv) (isolated from pCMVβ; BD Biosciences).
Rescue-A and -B, and ts+7/F-11C recombinants, were con-
structed from ts+7/F-Red2 with the Pcmv-Red2 sequence
replaced with the wild type oriL and the deleted oriL sequences,
respectively, together with the N-terminal portion of UL30.
These recombinant viruses were propagated in Vero cells, except
ts+7/F-Red2, which was propagated in PolA5 cells.
Plasmids
Plasmids ptkLTRZ1 (Davar et al., 1994) (kindly provided by
D.M. Coen) and pSupF-tk2 (Hwang and Hwang, 2003) have
been described previously. The plasmid series of pGEM-ts+7/
Lac Z-UL29 and pGEM-ts+7/F-UL29 were constructed as the
following. A 5.0-kb AvrII–BglII DNA fragment, which contains
the entire UL29 open reading frame, oriL, and the 5′ portion of
UL30, was isolated from infectious DNA of ts+7/Lac Z-A, -B,
and ts+7/F-C recombinants, respectively, and subcloned into the
XbaI–BamHI site of the pGEM7Zf(+) vector. The following
oligonucleotides ICP8-3 (corresponding to nucleotides 60,030
to 60,014 of the HSV-1 genome), ICP8-4 (59,849 to 59,864),
ICP8-5 (61,290 to 91,273), ICP8-3688 (61,192 to 61,211), oriL-
284 C. Jiang et al. / Virology 347 (2006) 277–2853′ (62,680 to 62,661), and T7 primer were used to sequence the
entire UL29 sequence.
Plasmid pUL29/30-Red2 (Fig. 2, line 3) was constructed in
the following way. A 1.2-kb DNA fragment, containing the N-
terminal portion of UL29 and a partial oriL sequence
(corresponding to nucleotides 61,188 to 62,419 of the HSV-1
genome), was amplified from HSV-1 genomic DNA by PCR
using primers ICP8-HindIII (5′-CCCAAGCTTCGAAGG-
CCGTGAACGTAATG-3′) and OriL-SphI (5′-ACATG-
CATGCCACGCCCACCGGCTGATGAC-3′). The PCR
products were cloned into the pCRT7/NT-TOPO vector
(Invitrogen) to construct plasmid pUL29-OriL. A 1.2-kb
SphI–EcoRI DNA fragment, containing the Pcmv-Red2 se-
quence, was cloned into the corresponding restriction sites in
pUL29-OriL to construct pUL29-OriL-Red2. A 2.4-kb EcoRI
fragment was isolated from pGEM3-pol (Hwang et al., 1997),
which contains the entire pol open reading frame, and was
inserted into UL29-OriL-Red2 to construct pUL29/30-Red2.
This plasmid contains 1.2 kb of UL29/OriL sequence and 2.4
kb of the pol gene sequence flanking the Pcmv-Red2 cassette
for subsequent construction of recombinant viruses expressing
DsRed2 protein. All restriction enzymes used in this study
were from New England Biolabs.
The plasmid pKS-UL29/30 (Fig. 2, line 5) was constructed
to contain the 4.4-kb ClaI–NotI DNA fragment [isolated from
viral genomic DNA of the wild type strain KOS (nucleotides
61,396 to 65,771)] and cloned into the pBluescript II KS (+)
vector (Stratagene). Recombination-negative E. coli Sure 2 host
cells (Stratagene) were used to propagate plasmid DNA to
prevent the loss of oriL sequence (Hardwicke and Schaffer,
1995).
The plasmid pKS-UL29/30-ΔOriL was constructed by the
following procedures. First a 514-bp DNA fragment was
amplified from ts+7/Lac Z-A-infected cell DNA using both
ICP8-2 and oriL-3′ primers. The PCR products were cleaved by
BsrGI and BamHI enzymes to obtain a 164-bp DNA fragment,
which lacked the oriL core sequences. This DNA fragment was
then used to replace the corresponding 312-bp fragment within
pKS-UL29/30 DNA clone. The run of 11 Cs is located upstream
of the BsrGI restriction site; therefore, the resulting plasmid
pKS-UL29/30-ΔOriL contains the run of 11 Cs and the deletion
of oriL.
Construction of recombinant viruses
Recombinant viruses tkLTR-Z1 and KOS/F-B (Fig. 1B,
line1) were described previously (Davar et al., 1994; Hwang et
al., 2002). To construct ts+7/Lac Z recombinant virus, the
plasmid ptkLTRZ1, which contains the Lac Z gene under control
of the Moloney murine leukemia virus LTR promoter (MoMLV-
LTR) (Davar et al., 1994), was co-transfected with ts+7
infectious viral DNA into 5 × 105 Vero cells using LipofectA-
mine 2000, according to the manufacturer's protocol (Invitro-
gen). Recombinants were isolated by plaque assay using Vero
cells, appearing as blue plaques after X-Gal staining. Two
independent recombinants, ts+7/Lac Z-A and -B (Fig. 1A), were
isolated from independent transfection experiments and twiceplaque-purified to homogeneity. Two independent recombi-
nants, ts+7/F-A and -C (Fig. 2, line 2), were constructed by co-
transfection of pSupF-tk2 and ts+7 infectious viral DNA into
Vero cells. Recombinant viruses were isolated and purified
under 10 μM gancyclovir (GCV) selection as described
previously (Hwang and Hwang, 2003).
To construct the rescue recombinants, pUL29/30-Red2 was
transfected into PolA5 cells using LipofectAmine 2000,
followed by superinfection with ts+7/F-C recombinant virus.
Progeny viruses were identified, isolated, and purified from
plaques expressing red fluorescence using an inverted fluores-
cent microscope (Nikon Eclipse TE300). Recombinant ts+7/F-
Red2 was purified to homogeneity and confirmed by PCR as
described below. Plasmid pKS-UL29/30, which contains wild
type UL29, oriL, and UL30 sequences, was transfected into Pol
A5 cells, followed by superinfection with ts+7/F-Red recom-
binant virus. Progeny viruses were identified and isolated by
plaque assay as those losing the expression of red fluorescence.
Two recombinants, rescue-A and -B, were constructed from two
independent transfection experiments, purified to homogeneity,
and verified by PCR amplification of the target sequences.
Recombinant virus ts+7/F-11C was constructed by transfec-
tion of pKS-UL29/30-ΔoriL DNA, which contained the
deletion of the oriL core sequences and 11Cs, into Pol A5
cells using LipofectAmine 2000, followed by superinfection
with ts+7/F-Red2 virus. Recombinant viruses were identified
and isolated as described above. The lack of oriL sequences and
the presence of 11 Cs was confirmed by sequencing the PCR
products amplified from the viral infected cell DNA.
Southern analysis, PCR amplification, and sequencing
Southern analysis was performed as described previously
(Hwang et al., 2002). PCR was performed using the following
program, except as noted below. PCR amplification was
performed in a 50-μl reaction containing 0.5 μg of infected
cell DNA, 1 μM of each primer, 200 μM of each dNTP, 5 units
Taq polymerase (Eppendorf), PCR buffer (Eppendorf), and 10%
glycerol. The reaction conditions included a 2-min incubation at
94 °C, 30 cycles of denaturation at 94 °C for 30 s, annealing at
60 °C for 30 s, and extension at 72 °C for 1 min, followed by a
final extension at 72 °C for 7 min. For PCR amplification of the
oriL-containing sequences, an annealing temperature of 65 °C
was applied, and primers ICP8-2 (5′-TTGATGGTGGTTG-
CCGTCTTG-3′) and oriL-3′ (5′-GCAAGGGCCTTGT-
TTGTCTG-3′), corresponding to sequences located upstream
and downstream of the oriL sequence (Fig. 2, line 6), were used.
PCR was used to amplify the pol gene from ts+7/F-A and
rescue-A-infected cell DNA using the primer sets described
previously (Hwang et al., 2004). The following primers were
used to amplify UL29-DsRed2: ICP8-2 and Red-545 (5′-
AGACAGCTTCTTGTAGTCGGGG-3′, corresponding to
nucleotides 533 to 545 of the DsRed2 coding sequence) (Fig.
2, lines 3 and 6). Primers UL42-2 (5′-GAGGAGGGC-
GTGTCGTCCAGCA-3′; corresponding to nucleotides 675 to
696 of the UL42 open reading frame) and UL42-8 (5′-
GTCTTAGGTTTCTTTAGGG-3′; nucleotides 1243 to 1225)
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products were sequenced using an ABI 3100 Genetic Analyzer
(Applied Biosystems) at the Upstate Medical University DNA
Core Facility or using an ABI PRISM® 3730XL Analyzer at
Macrogen. PCR products containing the oriL sequences were
sequenced using the fmol DNA cycle sequencing kit (Promega,
Madison), a 32P-labeled oriL-3′ primer, and a modified
annealing temperature of 72 °C.
Mutagenesis assays
SupF mutagenesis assay was used to examine the supF
mutation frequency replicated by the KOS/F, ts+7/F, and
rescued recombinant viruses, as described previously (Hwang
and Hwang, 2003; Hwang et al., 2002, 2004). Briefly, 100–200
pfu of the recombinant viruses was inoculated into 1 × 105 Vero
cells seeded in a culture tube. After absorption for 1 h, infected
cells were washed with serum-free DMEM and incubated for 72
h. DNAwas then extracted from the infected cells, purified, and
digested with BamHI. After self-ligation of BamHI-cleaved
DNA, an aliquot of DNAwas electroporated into the E. coli host
strain MBM7070. Transformants were then spread on LB agar
plates containing ampicillin, IPTG, and X-Gal. White and light
blue colonies were identified as mutants containing the mutated
SupF gene, and the relative mutation frequency was determined
as the ratio of the number of white plus light blue colonies to the
total number of colonies.
Recombinant viruses tkLTRZ1, ts+7/Lac Z-A, and -B were
used to examine the mutation frequency of the Lac Z gene as
previously described (Hwang et al., 2003). Briefly, 100 to 200
pfu of recombinant virus was inoculated into 2 × 105 Vero cells.
Progeny viruses were harvested at 72 h-post-infection.
Approximately 1200 to 1500 pfu of the progeny viruses was
plaque assayed on Vero cells seeded on 10-cm culture plate. The
cells were overlaid with 0.75% methylcellulose at 1 h-post-
infection. At 48 h-post-infection, the cells were fixed and
stained with X-gal using the β-galactosidase reporter gene
staining kit (Sigma). Clear foci (plaques) were identified by
inverted microscopy and mutation frequency was determined as
the ratio of the number of clear plaques to the total number of
plaques. A chi-square test was used to calculate the statistical
significance of the differences in mutation frequencies.
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